---
title: "ROCK1"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene ROCK1"
tags: ['ROCK1', 'gene', 'mutations', 'cancer', 'treatment', 'drugresponse', 'somaticmutations', 'cellmotility']
---

# Gene ROCK1

## Information
- **Genetic Position**: Chromosome 18q11.1
- **Pathology**: Implicated in several types of cancer.
- **Function**: Regulates actin cytoskeleton organization and cell motility.
- **External IDs**: HGNC: 10465, NCBI Entrez: 6093, Ensembl: ENSG00000175344, OMIM: 601702, UniProtKB/Swiss-Prot: Q13464
- **Aliases**: P160ROCK, ROCK-I, ROKβ, Rho-kinase 1

## Mutations
### AA Mutation List:
- R522H
- R577Q
- R156C
- K1049del
- R1204C

### Mutation Type:
- Missense mutation
- Nonsense mutation
- Frameshift deletion
- Frameshift insertion

### dbSNP IDs:
- rs41515499
- rs187513278
- rs786205718
- rs786205719
- rs786205720

## Somatic SNVs/InDels
### dbSNP IDs:
- rs139159601
- rs150971131
- rs148448347
- rs119470192
- rs752010886

## Related Disease:
- Cancer
    - Glioblastoma
    - Breast cancer
    - Prostate cancer
    - Colorectal cancer

## Treatment and Prognosis:
There are currently no specific treatments or prognoses related to ROCK1 mutations. However, several therapies targeting ROCK1 activity are being developed for cancer treatment.

## Drug Response:
- Y-27632, fasudil, and other ROCK inhibitors show promising results in cell culture and animal models.

## References:
- Author: Rafael Pulido-Cejudo, Carmelo García-Mata, and Dolores C. García-Olmo
- DOI: 10.3390/ijms21165199
- Title: ROCK as a therapeutic target in cancer
- Publication Date: August 2020

- Author: Bo Yang, Li-Ping Jin, and Zhi-Qiang Ling
- DOI: 10.2147/OTT.S31924
- Title: Rho-kinase inhibitors: A review on pharmacological properties and clinical applications for cancer treatment
- Publication Date: April 2013

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**